Skip to content
NAD+ Picks
← Research
Safety

503A or 503B: what your NAD⁺ seller means by it

Two sections of one federal law, quoted at you as if they were quality grades. One is a real difference in who inspects and to what standard — and neither makes a compounded drug FDA-approved.

Michael Reyes6 min read
Two kinds of compounding pharmacy503A — a pharmacyMakes it for one named patientNeeds a prescription firstOverseen by the state boardFDA inspects for causeCGMP does NOT apply503B — an outsourcing facilityMakes batches in advanceNo prescription needed to makeRegisters with the FDAFDA inspects on a scheduleCGMP DOES applyNeither makes the drug FDA-approved. Compounded drugs never are.

If you are buying NAD⁺ online you will meet one of these numbers. A seller will tell you its medicine comes from a “503A pharmacy” or a “503B facility”, usually in a sentence meant to reassure you, and usually without saying what it means. Of the 157 sellers we have reviewed, 23 name one of the two — far more than name the pharmacy itself, which is the answer you can actually check.

They are sections of a federal law, not quality grades. They describe how a pharmacy is allowed to operate and who inspects it. Knowing which one you are dealing with tells you something real — just not the thing the marketing implies.

If you are here because a checkout used the term at you, the short version is at the bottom. If you want the surrounding context first, what FDA approval means for NAD⁺ is the piece this one sits next to.

503A: made for you, after a prescription

This is the traditional compounding pharmacy. A licensed pharmacist prepares a medicine for one named patient, against a prescription that already exists. It is overseen primarily by the state board of pharmacy. The FDA describes its own role here as surveillance and for-cause inspections [1] — it looks when there is a reason to.

One thing follows from that and it is worth stating plainly. Drugs compounded under 503A are not subject to current good manufacturing practice requirements [1]. CGMP is the manufacturing standard that applies to the drugs in a pharmacy aisle. It does not apply here.

That matters most for injectables, where sterility is the risk that counts — the side-effect piece covers what actually goes wrong in practice.

503B: made in batches, inspected on a schedule

An outsourcing facility registers with the FDA and can compound in advance, in batches, without a prescription for a named person. In exchange it takes on more oversight: the FDA says outsourcing facilities are primarily overseen by FDA and inspected by FDA on a risk-based schedule, and that drugs compounded there are subject to CGMP [1].

So on the two things a buyer might care about — who inspects, and to what standard — 503B is the more heavily regulated of the two. That is a real difference and it is reasonable for a seller to mention it.

What neither one means

Neither makes the medicine FDA-approved. The FDA’s own answer is unambiguous: compounded drugs are not FDA-approved, which means FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed [2]. That is true of every compounded NAD⁺ product sold, from either kind of pharmacy, at any price.

So a sentence like “compounded in an FDA-registered facility” is doing something subtle. Registration is a fact about the building. Approval is a judgment about the drug. The sentence is true and it is not the reassurance it sounds like — we have a separate piece on that distinction because it comes up constantly.

The question that actually tells you something

Here is what we found doing this across the whole roster. 23 sellers name a 503 designation. Only 10 of 157 name the pharmacy itself.

That gap is the useful signal. A designation is a category that thousands of businesses share, and quoting it costs a seller nothing. A name is checkable. You can look up a named pharmacy’s state license, its inspection history, whether it has been the subject of a recall. You cannot look up “a licensed 503A pharmacy”.

So the question worth asking is not which section they operate under. It is which pharmacy, by name. A seller who will answer that has told you something you can verify. A seller who answers with a section number has told you something you cannot.

What to do with this

  • If a seller says 503B, that is genuinely more oversight than 503A. Note it, do not over-read it.
  • If a seller says 503A, that is the ordinary case for a patient-specific prescription. It is not a warning sign by itself.
  • If a seller says “FDA-registered” and stops, read it as a fact about a building.
  • Ask for the pharmacy’s name either way. That is the answer that can be checked.

Our provider reviews record which sellers name their pharmacy and which do not, and the safety piece covers what compounding means for the product itself.

Frequently asked

Is 503B better than 503A?
On oversight, yes. FDA says outsourcing facilities registered under 503B are primarily overseen and inspected by FDA on a risk-based schedule, and drugs compounded there are subject to CGMP requirements. Drugs compounded under 503A are not subject to CGMP, and FDA's role there is surveillance and for-cause inspection. That is a real difference. It is not a statement about any individual pharmacy's quality.
Does a 503B facility make the NAD⁺ FDA-approved?
No. FDA states plainly that compounded drugs are not FDA-approved, and that it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. That applies to compounded NAD⁺ from either kind of pharmacy.
My seller says its pharmacy is FDA-registered. Is that the same as 503B?
Outsourcing facilities do register with FDA, so the phrase often points that way. But registration is a fact about a facility, not a review of the medicine, and the phrase is sometimes used loosely. If it matters to you, ask which section the pharmacy operates under and what it is called.
Why does it matter whether the pharmacy is named?
Because a name is checkable and a category is not. You can look up a named pharmacy's state license and inspection history. Across the sellers we review, many quote a 503 designation and only a few name the pharmacy — so asking for the name separates the two.

Sources

  1. [1] U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers — quality standards and oversight of 503A pharmacies and 503B outsourcing facilities FDA.gov. Source
  2. [2] U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers — are compounded drugs approved by FDA? FDA.gov. Source

More in Safety